[home]
[thesaurus]
Click Here to return To Results
Intravenous Dihydroergotamine for Inpatient Management of Refractory Primary Headaches
Neurol 77:1827-1832, Nagy, A.J.,et al, 2011
See this aricle in Pubmed
Article Abstract
Intravenous dihydroergotamine is well-tolerated, and longer treatments produce a better outcome. Nausea is the most common adverse effect, and its control associated with a better outcome.
Related Tags
(click to filter results - removes previous filter)
adverse drug reaction
cluster headache
efficacy
ergotamine
headache
headache,intractable
headache,treatment of
hospitalization
intravenous
migraine
migraine,chronic
nausea and vomiting
safety
treatment of neurologic disorder
Click Here to return To Results